Menu
GeneBe

TSFM

Ts translation elongation factor, mitochondrial

Basic information

Region (hg38): 12:57782760-57808071

Links

ENSG00000123297NCBI:10102OMIM:604723HGNC:12367Uniprot:P43897AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Supportive), mode of inheritance: AR
  • Leigh syndrome (Moderate), mode of inheritance: AR
  • fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Combined oxidative phosphorylation deficiency 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic17033963; 21119709; 22499341

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TSFM gene.

  • not provided (380 variants)
  • Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (93 variants)
  • Inborn genetic diseases (28 variants)
  • not specified (12 variants)
  • Nephrotic syndrome, type 21 (2 variants)
  • See cases (2 variants)
  • Encephalomyopathy with respiratory failure and lactic acidosis (2 variants)
  • Combined oxidative phosphorylation deficiency (1 variants)
  • Primary dilated cardiomyopathy (1 variants)
  • Steroid-resistant nephrotic syndrome (1 variants)
  • Skeletal myopathy (1 variants)
  • - (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSFM gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
127
clinvar
3
clinvar
133
missense
1
clinvar
3
clinvar
117
clinvar
3
clinvar
4
clinvar
128
nonsense
8
clinvar
11
clinvar
1
clinvar
20
start loss
5
clinvar
5
frameshift
11
clinvar
16
clinvar
1
clinvar
28
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
8
clinvar
8
splice region
3
29
32
non coding
24
clinvar
37
clinvar
13
clinvar
74
Total 20 38 152 167 20

Highest pathogenic variant AF is 0.0000329

Variants in TSFM

This is a list of pathogenic ClinVar variants found in the TSFM region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-57782794-C-A not specified Likely benign (Dec 03, 2015)381395
12-57782802-A-G Uncertain significance (Feb 04, 2022)2061807
12-57782802-A-T Uncertain significance (Jul 06, 2022)1940093
12-57782803-T-C Uncertain significance (May 23, 2023)1959263
12-57782803-T-G Skeletal myopathy Uncertain significance (Oct 12, 2015)222856
12-57782804-G-A Uncertain significance (May 29, 2021)1484444
12-57782803-T-TGTCGCTGCTGCG Uncertain significance (Jun 22, 2022)2162512
12-57782806-C-A Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Pathogenic/Likely pathogenic (Jul 29, 2023)2679363
12-57782806-C-T Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Benign (Jan 30, 2024)703844
12-57782807-G-C Likely benign (Dec 09, 2023)2802836
12-57782808-C-T Likely benign (Nov 03, 2023)754650
12-57782810-G-A Likely benign (Mar 09, 2022)2108144
12-57782810-G-T Likely benign (Jul 10, 2023)3000027
12-57782811-C-T Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Likely benign (Jan 05, 2024)1126237
12-57782812-T-C Uncertain significance (Jan 07, 2022)2157310
12-57782813-G-A Likely benign (Dec 01, 2023)1555751
12-57782813-G-T Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Likely benign (Jan 22, 2024)705419
12-57782814-C-A Likely benign (Oct 22, 2023)1672834
12-57782818-C-A Pathogenic (Jan 15, 2022)1361252
12-57782818-C-G Uncertain significance (Jun 07, 2022)1953006
12-57782818-C-T Inborn genetic diseases Uncertain significance (Jan 23, 2024)3183605
12-57782820-C-T Likely benign (Sep 29, 2021)1653120
12-57782822-G-T Likely benign (Nov 12, 2023)2860457
12-57782823-C-T Inborn genetic diseases Uncertain significance (Oct 17, 2022)2073038
12-57782824-G-C Uncertain significance (Jun 07, 2021)1359716

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TSFMprotein_codingprotein_codingENST00000323833 725483
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.92e-90.13212521403941256080.00157
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2171771691.050.000008292167
Missense in Polyphen5963.4880.92931787
Synonymous-0.5187771.41.080.00000368712
Loss of Function0.2471415.00.9317.26e-7198

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006430.000639
Ashkenazi Jewish0.0002000.000199
East Asian0.0001640.000163
Finnish0.01450.0138
European (Non-Finnish)0.0006430.000599
Middle Eastern0.0001640.000163
South Asian0.000.00
Other0.001240.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Associates with the EF-Tu.GDP complex and induces the exchange of GDP to GTP. It remains bound to the aminoacyl-tRNA.EF- Tu.GTP complex up to the GTP hydrolysis stage on the ribosome. {ECO:0000255|HAMAP-Rule:MF_03135, ECO:0000269|PubMed:27677415}.;
Pathway
Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation (Consensus)

Recessive Scores

pRec
0.199

Intolerance Scores

loftool
0.376
rvis_EVS
-0.03
rvis_percentile_EVS
51.92

Haploinsufficiency Scores

pHI
0.175
hipred
N
hipred_score
0.394
ghis
0.533

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.513

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tsfm
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; vision/eye phenotype;

Gene ontology

Biological process
translational elongation;regulation of DNA-templated transcription, elongation;mitochondrial translational elongation;regulation of mitochondrial translation
Cellular component
nucleus;mitochondrion;mitochondrial matrix
Molecular function
RNA binding;translation elongation factor activity;protein binding